CENTOGENE NV (CNTG)

NL0014040206 - Common Stock

0.69  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CNTG. CNTG was compared to 116 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of CNTG have multiple concerns. CNTG is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year CNTG has reported negative net income.
CNTG had a negative operating cash flow in the past year.
CNTG had negative earnings in each of the past 5 years.
In the past 5 years CNTG reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -44.28%, CNTG is doing worse than 85.34% of the companies in the same industry.
Industry RankSector Rank
ROA -44.28%
ROE N/A
ROIC N/A
ROA(3y)-33.25%
ROA(5y)-26.46%
ROE(3y)-211.62%
ROE(5y)-142.25%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of CNTG (41.96%) is better than 70.69% of its industry peers.
CNTG's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CNTG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.5%
GM growth 5Y-4.51%

2

2. Health

2.1 Basic Checks

CNTG does not have a ROIC to compare to the WACC, probably because it is not profitable.
CNTG has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CNTG has more shares outstanding
Compared to 1 year ago, CNTG has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -1.03, we must say that CNTG is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.03, CNTG is doing worse than 73.28% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.03
ROIC/WACCN/A
WACC10.67%

2.3 Liquidity

CNTG has a Current Ratio of 1.45. This is a normal value and indicates that CNTG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.45, CNTG is in line with its industry, outperforming 58.62% of the companies in the same industry.
CNTG has a Quick Ratio of 1.37. This is a normal value and indicates that CNTG is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.37, CNTG is doing good in the industry, outperforming 61.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.37

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.07% over the past year.
The Revenue has grown by 12.41% in the past year. This is quite good.
The Revenue has been growing by 8.42% on average over the past years. This is quite good.
EPS 1Y (TTM)31.07%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-130.96%
Revenue 1Y (TTM)12.41%
Revenue growth 3Y-0.9%
Revenue growth 5Y8.42%
Revenue growth Q2Q119.86%

3.2 Future

CNTG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.16% yearly.
Based on estimates for the next years, CNTG will show a quite strong growth in Revenue. The Revenue will grow by 12.05% on average per year.
EPS Next Y-14.93%
EPS Next 2Y14.16%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.6%
Revenue Next 2Y12.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

CNTG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CNTG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as CNTG's earnings are expected to grow with 14.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.16%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CNTG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CENTOGENE NV

NASDAQ:CNTG (3/27/2024, 8:06:22 PM)

0.69

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap19.23M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.28%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 41.96%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.45
Quick Ratio 1.37
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)31.07%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-14.93%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.41%
Revenue growth 3Y-0.9%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y